Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31
Pricing can change
PIONEER 1: Randomized clinical trial of the efficacy and safety of oral semaglutide monotherapy in comparison with placebo in patients with type 2 diabetes
Providing a treatment option that is proven to lower this cardiovascular risk is a major advance for public health. The FDAs decision is largely based on data from the SELECT trial, which included more than 17,000 overweight or obese patients with a baseline age of 45 years old
PMCID: PMC5990155 ) Prez E, Martnez-Tadeo J, Callero A, Hernndez G, Rodrguez-Plata E, Garca-Robaina JC (2014) A case report of allergy to exenatide
Others notice gradual improvement over longer periods
US$ 21.11
US$ 28.93
US$ 28.64
US$ 20.00
US$ 27.68
US$ 28.09
US$ 23.32
US$ 29.20
US$ 26.68
